share_log

回盛生物:武汉回盛生物科技股份有限公司2024年度向特定对象发行A股股票募集资金使用可行性分析报告

Huisheng Biotech: Feasibility Analysis Report on the Use of Funds Raised by Wuhan Huisheng Biotechnology Co., Ltd. to issue A-shares to specific targets in 2024

深证信a股 ·  Apr 3
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more